| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |